Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Schizophr Res. 2013 Nov 5;151(0):124–132. doi: 10.1016/j.schres.2013.10.017

Table 1.

Demographic and Clinical Characteristics of Participants

Schizophrenia
n = 23		 Control
n = 21
Sex (male/female) 12/11 11/10
Race (black/white/other) 10/13/0 7/13/1
Age, Years 43.35 (11.8) 42.38 (10.0)
Participant’s Education, Years* 13.70 (2.5) 15.76 (2.3)
Parental Education, Years 13.18 (2.7) 13.40 (2.4)
IQ, NART 106.17 (8.5) 109.29 (8.3)
Ham-D 3.44 (3.5) -
YMRS .97 (2.3) -
PANSS- Total 51.35 (13.0) -
PANSS- Positive 13.22 (5.6) -
PANSS- Negative 14.13 (6.7) -
PANSS- General 24.0 (5.5) -
CPZ 521.13 (261.8) -
Duration of Illness, Years 20.09 (10.8) -
Number of Hospitalizations 4.87 (4.3) -

CPZ, chlorpromazine equivalent doses; HAM-D, Hamilton Depression Rating Scale; NART, North American Adult Reading Test; PANSS, Positive and Negative Syndrome Scale; YMRS, Young Mania Rating Scale.

*

Control > Schizophrenia, p < .05